Drug class
Piperazine derivative; antihistamine with calcium-channel-blocking activity; antivertigo agent
Mechanism of action
Has antihistaminic activity and inhibits calcium-ion transport across cell membranes. Its calcium-antagonist activity reduces vestibular sensory-cell calcium influx; it also has central vestibular-sedative and antiemetic effects.
General use cases
- Control of vestibular disorders such as vertigo, tinnitus, nausea and vomiting associated with Ménière’s disease or other labyrinthine disorders
- Prevention and control of motion sickness
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
